Access cutting-edge lung cancer treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Anchorage at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, KEAP1, or KRAS.
Sponsor: AstraZeneca
Check if you qualify for this lung cancer clinical trial in Anchorage, AK
If you're searching for lung cancer treatment options in Anchorage, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.